4//SEC Filing
Pierce David A 4
Accession 0001225208-22-003867
CIK 0000885725other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:29 PM ET
Size
9.6 KB
Accession
0001225208-22-003867
Insider Transaction Report
Form 4
Pierce David A
SVP and President, Endoscopy
Transactions
- Exercise/Conversion
Common Stock
2022-02-28+2,444→ 2,444 total - Tax Payment
Common Stock
2022-02-28$44.17/sh−718$31,714→ 1,726 total - Sale
Common Stock
2022-03-01$43.94/sh−1,726$75,840→ 0 total - Exercise/Conversion
Deferred Stock Units
2022-02-28−2,444→ 0 totalExp: 2022-02-28→ Common Stock (2,444 underlying)
Footnotes (3)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001529751
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:29 PM ET
- Size
- 9.6 KB